BioSpace News Archive

Funding completed in subsidiary without dilution to BioSig common stock Phase II human trials for merimepodib, a broad-spectrum oral anti-viral treatment of adult hospitalized patients with COVID-19, are planned to commence at three Mayo Clinic sites BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced the closing of a $10.8 million common stock financ

The longitudinal research study will leverage Babson’s serology testing services to inform the diagnosis and treatment of COVID-19

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today released a letter (below) from Mihael H. Polymeropoulos , M.D., President and CEO of Vanda Pharmaceuticals, proposing an approach to Clinical Trial Data Sharing in order to facilitate discovery and clinical utility of COVID-19 therapeutics. Vanda is also involved in the development of

Echosens , a high-technology company offering the FibroScan family of products, today announces the release of its white paper, “ Two-Fold Epidemic: Fatty Liver Disease and Obesity Demand Proactive Steps, Earlier Identification of Liver Damage .” The paper examines key aspects of the entwined epidemics of obesity and fatty liver disease and highlights the importance of greater patient engagement and leveraging innovative

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO).

BIOQUAL announces the release of two research publications in Science Magazine of our non-human primate model development efforts and our first successful testing of a COVID-19 vaccine candidate

Personal Genomics Taiwan, Inc. (“PGI”), today announced that it has filed a patent infringement complaint in the Wuhan People’s Court in China against Pacific Biosciences of California, Inc. (“PacBio”).

Today, 20 May 2020, the annual general meeting was held in AlzeCure Pharma AB (publ). Below is a summary of the resolutions made. All resolutions were passed with the required majority.

Olympus is hosting two live webinars, May 21-22, to address the specific concerns raised by customers during the SARS-CoV2 pandemic.

Zomedica, a veterinary diagnostic company, announced that it has completed the final verification of three additional assays for use with its TRUFORMA™ point-of-care diagnostic platform.